Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2025.12.05

NAV

16,906KRW

-467.89하락 (-2.69%)

Market Price per share (KRW)

16,945KRW

-455하락 (-2.61%)

※ t-1 last price

trading volume

27,590shares

AUM

KRW 10.1billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2025.12.05
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 10,143,826,525
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 16,945
※ t-1 last price 		16,906 27,590
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
10,143,826,525 하나은행
Market Price per share (KRW) iNAV per share (KRW)
16,945
※ t-1 last price 		16,906
Trading Volume (shares)
27,590
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2025-12-05
Rank , Name, proportion table
Rank Name Weight (%)
1 Alteogen 10.40
2 Celltrion 9.14
3 SAMSUNG BIOLOGICS 8.70
4 ABL Bio 8.14
5 Yuhan 7.93
6 HLB 6.78
7 LCB 6.16
8 SKBP 4.46
9 SCD 3.73
10 PharmaResearch 3.36

proportion by sectors

*The proportion of investment stocks

Update : 2025.12.05
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2025-12-05

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV 3.29 11.75 22.09 26.88 61.17 21.05 66.69
Benchmark Index 3.35 11.97 22.49 27.34 61.47 21.61 68.25
Outperformance -0.07 -0.23 -0.4 -0.47 -0.3 -0.56 -1.57

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2025.12.05 16,945 -2.614하락 16,906.38 -2.693하락 10,358.12
2025.12.04 17,400 0.432상승 17,374.27 0.243상승 10,358.17
2025.12.03 17,325 -0.345하락 17,331.98 -0.169하락 10,358.21
2025.12.02 17,385 0.375상승 17,361.44 -0.236하락 10,358.25
2025.12.01 17,320 0.903상승 17,402.56 0.985상승 10,358.3
2025.11.28 17,165 2.324상승 17,232.87 2.753상승 10,354.43
2025.11.27 16,775 0.328상승 16,771.15 0.100상승 10,354.48
2025.11.26 16,720 3.146상승 16,754.38 3.245상승 10,354.52
2025.11.25 16,210 -1.935하락 16,227.72 -1.771하락 10,354.56
2025.11.24 16,530 -1.283하락 16,520.42 -1.099하락 10,354.61
2025.11.21 16,745 -1.644하락 16,704.24 -1.681하락 10,354.74
2025.11.20 17,025 2.007상승 16,989.92 2.045상승 10,354.78
2025.11.19 16,690 -1.591하락 16,649.29 -1.546하락 10,354.82
2025.11.18 16,960 -1.965하락 16,910.73 -2.076하락 10,354.87
2025.11.17 17,300 0.028상승 17,269.32 0.109상승 10,354.91
2025.11.14 17,295 0.757상승 17,250.46 0.664상승 10,355.04
2025.11.13 17,165 2.294상승 17,136.57 2.887상승 10,355.09
2025.11.12 16,780 6.438상승 16,655.59 5.589상승 10,355.13
2025.11.11 15,765 -1.561하락 15,773.91 -1.290하락 10,355.17
2025.11.10 16,015 0.596상승 15,980.07 0.573상승 10,355.21
2025.11.07 15,920 -1.728하락 15,889 -2.254하락 10,355.34
2025.11.06 16,200 -0.917하락 16,255.48 -0.685하락 10,355.38

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Alteogen KR7196170005 174 10.4 90,306,000
2 Celltrion KR7068270008 435 9.14 79,431,000
3 SAMSUNG BIOLOGICS KR7207940008 45 8.7 75,600,000
4 ABL Bio KR7298380007 352 8.14 70,752,000
5 Yuhan KR7000100008 582 7.93 68,908,800
6 HLB KR7028300002 1,220 6.78 58,926,000
7 LCB KR7141080002 273 6.16 53,535,300
8 SKBP KR7326030004 284 4.46 38,709,200
9 SCD KR7000250001 145 3.73 32,407,500
10 PharmaResearch KR7214450009 71 3.36 29,181,000
11 HanmiPharm KR7128940004 66 3.27 28,380,000
12 HANALL BIOPHARMA KR7009420001 368 2.37 20,608,000
13 ST Pharm KR7237690003 131 1.78 15,444,900
14 SKBS KR7302440003 276 1.73 15,014,400
15 원화예금 KRD010010001 13,859,122 1.6 13,859,122
16 SAMSUNG EPIS HOLDINGS KR70126Z0002 24 1.54 13,368,000
17 Celltrionph KR7068760008 210 1.5 13,041,000
18 Hugel KR7145020004 55 1.4 12,155,000
19 L&C BIO KR7290650001 173 1.3 11,331,500
20 CLASSYS KR7214150005 182 1.15 10,028,200
21 Pharmicell KR7005690003 583 1.14 9,945,980
22 CHA Biotech KR7085660009 556 1 8,695,840
23 SEEGENE KR7096530001 334 0.99 8,567,100
24 DAEWOONG PHARM KR7069620003 47 0.97 8,469,400
25 Hanmi Science KR7008930000 212 0.91 7,865,200
26 HK inno.N KR7195940002 148 0.9 7,784,800
27 GC Corp KR7006280002 57 0.9 7,820,400
28 MedyTox KR7086900008 57 0.83 7,216,200
29 ShinpoongPharm KR7019170000 345 0.58 5,043,900
30 DongKook Pharm KR7086450004 244 0.53 4,611,600
31 HLBPHARMA KR7047920004 290 0.52 4,521,100
32 Binex KR7053030003 300 0.5 4,311,000
33 CUREXO KR7060280005 302 0.49 4,228,000
34 EuBio KR7206650004 324 0.46 4,020,840
35 DENTIUM KR7145720009 69 0.41 3,539,700
36 SD Biosensor KR7137310009 364 0.39 3,396,120
37 BIONEER KR7064550007 231 0.38 3,296,370
38 WONTECH KR7336570007 448 0.38 3,310,720
39 SELVAS AI KR7108860008 247 0.37 3,198,650
40 Huons Global KR7084110006 57 0.36 3,089,400
41 T&L KR7340570001 48 0.28 2,409,600
42 BioPlus KR7099430001 432 0.27 2,384,640
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.